Dan Shen agents for acute ischaemic stroke

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Wu, B ^b   Liu, Ming ^a   Zhang, S ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

*Salvia miltiorrhiza; Acute disease; Brain ischemia drug therapy ; Chinese herbal *therapeutic use ; Drugs; Humans; Randomized controlled trials as topic; Stroke *drug therapy

Indexed keywords

PLACEBO; SALVIA MILTIORRHIZA EXTRACT;

ACUTE DISEASE; ALLERGY; BLOOD DISEASE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIZZINESS; DROWSINESS; FOLLOW UP; HEART DISEASE; HUMAN; LIVER DISEASE; LUNG DISEASE; NAUSEA; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SALVIA MILTIORRHIZA; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 44949194807     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004295.pub3     Document Type: Review

References (25)

1. Cao 1994 {published data only} *Cao P, Feng R, Feng Z. Observation of Compound Dan Shen injection and snake venom for cerebral infarction. Chinese Traditional Medicine of Guangxi 1994;17(4):3- 4,8.
2. Mao 2001 {published data only} *Mao J, Gan Z. Observation of Compound Dan Shen dropping pill for cerebral infarction. Pharmacological Magazine of People's Liberation Army 2001;17(1): 49-50.
3. Min 2004 {published data only} Min LQ, Yuan J, Li X, Ding ZY, Ma WY, Tian BX, et al.Influence of composite salvia miltiorrhiza on vascular endothelial cell function in patients with cerebral infarction. Chinese Journal of Clinical Rehabilitation 2004;8(16):3090-1.
4. Pan 1992 {published data only} *Pan C, Chen N, Huo J. 187 cases of Compound Dan Shen injection and snake venom for cerebral infarction. Chinese Traditional Medicine of Shanxi 1992;13(2):157- 8.
5. Zhai 2001 {published data only} Zhai ZL, Sun JH, Zhang J. A large dose of Dan Shen for acute ischaemic stroke. HeBei Medicine 2001;7(12):1110-1.
6. Zhang 2002 {published data only} Zhang LJ, Zhang BF, Tian F. Compound Dan Shen combined with heparin for acute ischaemic stroke. Zhejiang Journal of Integrated Tra-ditional Chinese and Western Medicine 2002;12(7):423.
7. Geng 2000 *Geng Z, Yao J. Compound Dan Shen for acute ischaemic stroke. Research of Traditional Chinese Medicine 2000;16(4):30-1.
8. Xu 1995 *Xu M. Observation of effect of Compound Dan Shen injection and XueShuangtong injection on cerebral infarction. Chinese Traditional Medicine of Guangxi 1995;18(5):4-5,7.
9. Gao 1998 *Gao Y, Mao L, Zhao W, Guo J. Clinical research of Compound Dan Shen dropping pill for cerebral infarction. Proceedings of Forum of Internationalized Chinese Materia Medica. 1998:65-6.
10. Liang 1996 *Liang Z. Observation of effect of Compound Dan Shen injection on ischaemic cerebrovascular diseases. Medicine of Guangdong 1996;17(9):626-7.
11. Luo 1998 *Luo S. Clinical observation on 78 cases of cerebral vascular accident treated by acupoint injection and acupuncture. Shanghai Journal of Acupuncture and Moxibustion 1998;2:12-3.
12. APT 1994 Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - 1: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
13. CMMCC 1998 Chinese Materia Medica Compiling Committee of the National Administration Bureau of Traditional Chinese Medicine. Radix Salviae Miltiorrhizae. Chinese Materia Medica. Vol. 1, Shanghai: Shanghai Science and Technology Press, 1998:1654-63.
14. Duncan 2000 Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trial: a systematic review and some recommendations to improve practice. Stroke 2000;31:1429-38.
15. Hatano 1976 Hatano S. Experience from a multicenter stroke register: a preliminary report. Bulletin of the World Health Organization 1976;54:541-53.
16. Horn 2001 Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001;32:570-6.
17. IST 1997 International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
18. Jin 1978 Jin HM. Clinical uses and studies of the mechanism of Dan Shen. Journal of Chinese Medicine 1978;3:180-3.
19. Li 2000 Li JL, Liu H. Compound Dan Shen Injection for non-cardiocerebrovascular diseases. Research of Traditional Chinese Medicine 2000;16(1):57-8.
20. Liang 2000 Liang Y, Yang YM, Yuan SHL. Studies of the pharmacological effect and the clinical use of tanshinone. Chinese Traditional and Herbal Drugs 2000;31(4):304-6.
21. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ. Empirical evidence of bias: dimension of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
22. Sulter 1999 Sulter G, Steen C, De Keyser J. Use of the Barthel Index and modified Rankin Scale in acute stroke trials. Stroke 1999;30:1538-41.
23. Sze 2005 Sze FK-h, Yeung FF, Wong E, Lau J. Does Danshen improve disability after acute ischaemic stroke?. Acta Neurologica Scandinavica 2005;111:118-25.
24. Tianjin 1998 Tianjin Talisco Pharmaceutical Group Co Ltd. Approval of Compound Danshen Dropping Pill (DSP) by FDA through pre-IND for clinical trials. Proceedings of Forum of Internationalized Chinese Materia Medica. 1998:18-30.
25. Wardlaw 2002 Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2002, Issue 1.Art. No.: CD000213. DOI:10.1002/14651858.CD000213.